Centessa Pharmaceuticals plc (CNTA)
NASDAQ: CNTA · Real-Time Price · USD
22.02
+0.21 (0.94%)
At close: Sep 15, 2025, 4:00 PM EDT
22.29
+0.27 (1.25%)
After-hours: Sep 15, 2025, 4:21 PM EDT

Centessa Pharmaceuticals Stock Forecast

Stock Price Forecast

The 10 analysts that cover Centessa Pharmaceuticals stock have a consensus rating of "Strong Buy" and an average price target of $30.6, which forecasts a 39.00% increase in the stock price over the next year. The lowest target is $19 and the highest is $38.

Price Target: $30.6 (+39.00%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price$19$30.6$31$38
Change-13.70%+39.00%+40.81%+72.61%

Analyst Ratings

The average analyst rating for Centessa Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingApr '25May '25Jun '25Jul '25Aug '25Sep '25
Strong Buy466777
Buy444444
Hold111000
Sell000000
Strong Sell000000
Total91111111111

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Wells Fargo
Wells Fargo
Buy
Initiates
$31
BuyInitiates$31+40.81%Sep 3, 2025
Chardan Capital
Chardan Capital
Strong Buy
Maintains
$30
Strong BuyMaintains$30+36.27%Aug 12, 2025
Chardan Capital
Chardan Capital
Strong Buy
Maintains
$30
Strong BuyMaintains$30+36.27%Jul 30, 2025
Truist Securities
Truist Securities
Strong Buy
Initiates
$30
Strong BuyInitiates$30+36.27%Jul 21, 2025
Needham
Needham
Strong Buy
Initiates
$35
Strong BuyInitiates$35+58.98%May 28, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
15.30M
Revenue Next Year
n/a
from 15.30M
EPS This Year
-1.41
from -2.06
EPS Next Year
-1.68
from -1.41
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
---6.85M-15.30M-
Revenue Growth
-------
EPS
-0.71-5.07-2.31-1.57-2.06-1.41-1.68
EPS Growth
-------
Forward PE
-------
No. Analysts
-----1514
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue20252026202720282029
High15.8Mn/a
Avg15.3Mn/a
Low14.7Mn/a

Revenue Growth

Revenue Growth20252026202720282029
High--
Avg--
Low--

EPS Forecast

EPS20252026202720282029
High-1.26-1.44
Avg-1.41-1.68
Low-1.47-1.99

EPS Growth

EPS Growth20252026202720282029
High--
Avg--
Low--
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.